Приказ основних података о документу
Novelties in dosage form design of the cardiovascular drugs
Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova
dc.creator | Ibrić, Svetlana | |
dc.creator | Parojčić, Jelena | |
dc.creator | Jakšić, Ivana | |
dc.creator | Đurić, Zorica | |
dc.date.accessioned | 2019-09-02T11:15:28Z | |
dc.date.available | 2019-09-02T11:15:28Z | |
dc.date.issued | 2008 | |
dc.identifier.issn | 0004-1963 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/1148 | |
dc.description.abstract | Contemporary trends in dosage form development for cardiovascular therapeutics are orientated toward rationalization and individualization of drug administration with the achievement of good compliance. Therefore, novelties in formulation development of cardiovascular drugs are directed towards the modified drug delivery systems. There is a number and variety of new technologies employed with this respect. In the present paper, and overview of the most important technologies applied in commercially available drug products within the group of cardiovascular drugs is given, such as extended release tablets/capsules, multiparticulate drug delivery systems, pulsatile drug delivery and OrosTM technology. | en |
dc.description.abstract | Savremen farmaceutsko-tehnološki pristup formulaciji preparata u terapiji kardiovaskularnih oboljenja vezan je, pre svega, za individualizaciju i racionalizaciju terapije uz obezbeđenje dobre prihvatljivosti od strane pacijenta i smanjenje neželjenih efekata. U skladu sa tim, novine u formulaciji farmaceutskih oblika sa kardiovaskularnim lekovima odnose se, uglavnom, na razvoj novih, 'naprednih' terapijskih sistema, tj. preparata sa modifikovanim oslobađanjem lekovite supstance. U radu je dat je pregled tehnologija zastupljenih u komercijalno dostupnim preparatima koji se koriste u terapiji kardiovaskularnih oboljenja, s posebnim osvrtom na tablete/kapsule sa modifikovanim oslobađanjem, višečestične terapijske sisteme, preparate sa pulsnim oslobađanjem lekovite supstance i OrosTM terapijske sisteme. | sr |
dc.publisher | Savez farmaceutskih udruženja Srbije, Beograd | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-sa/4.0/ | |
dc.source | Arhiv za farmaciju | |
dc.subject | cardiovascular drugs | en |
dc.subject | tablets | en |
dc.subject | capsules | en |
dc.subject | drug delivery systems | en |
dc.subject | modified release | en |
dc.subject | lekovi u terapiji kardiovaskularnih oboljenja | sr |
dc.subject | modifikovano oslobađanje | sr |
dc.subject | tablete | sr |
dc.subject | kapsule | sr |
dc.subject | terapijski sistemi | sr |
dc.title | Novelties in dosage form design of the cardiovascular drugs | en |
dc.title | Farmaceutsko-tehnološki aspekti savremenih kardiovaskularnih lekova | sr |
dc.type | article | |
dc.rights.license | BY-SA | |
dcterms.abstract | Паројчић, Јелена; Ђурић, Зорица; Јакшић, Ивана; Ибрић, Светлана; Фармацеутско-технолошки аспекти савремених кардиоваскуларних лекова; Фармацеутско-технолошки аспекти савремених кардиоваскуларних лекова; | |
dc.citation.volume | 58 | |
dc.citation.issue | 5-6 | |
dc.citation.spage | 432 | |
dc.citation.epage | 442 | |
dc.citation.other | 58(5-6): 432-442 | |
dc.identifier.fulltext | https://farfar.pharmacy.bg.ac.rs//bitstream/id/117/1146.pdf | |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_1148 | |
dc.type.version | publishedVersion |